Epidemiology and prognosis in young lung cancer patients aged under 45 years old in northern China

Abstract

To explore the epidemiological characteristics and prognosis of lung cancer in patients aged under 45 years old in northern China. The population-based database about lung cancer cases aged under 45y selected form the Hebei Provincial Cancer Registry Center from 2010–2015. Mortality data of young death from 1973 to 1975, 1990 to 1992, and 2004 to 2005 were extracted from the national retrospective survey of death. Mortality rates were calculated by the mortality database above in this analysis. Consecutive, 954 non-selected younger patients (< 45 years) and 2261 selected older patients (≥ 45 years) with pathologically diagnosed lung cancer treated at the Fourth Hospital of Hebei Medical University were included as the hospital-based database. Epidemiological, treatment outcomes and prognosis status from 2010 to 2017 were documented. A comparison with younger and older patients was also made. Multivariate analysis with young lung cancer patients was calculated by Cox regression model. The younger lung cancer mortality rate tended to slightly increase in Hebei Province, from 1.04 per100 000 in 1973 to 2.01 per 100 000 in 2015, but the PDR tended to decrease over the last 40 years. There were 954 younger and 2261 older lung cancer patients included in the hospital-based database. The proportions of patients who were female (50.84% vs 34.85%), family history of cancer (12.37% vs 6.32%), advanced stage at diagnosis (65.46% vs 60.77%) and adenocarcinoma (65.27% vs 61.11%) were relatively higher in the younger group than in the older group. The median OS were 23.0 months and 27.0 months between younger and older, the OS difference existed between the two groups (P = 0.001). In the younger patients, Cox regression showed that a family history of cancer, symptoms at diagnosis, pathology, stage at diagnosis and surgery were confirmed as independent factors affecting the prognosis. Mortality rates among younger lung cancer patients showed an increasing trend in northern China. The younger account for small but have unique characteristics, with higher proportions of female, family history of cancer, adenocarcinoma and advanced stages than the older group and had a trend of worse OS.

Clinical features and surgical outcomes of young patients with lung adenocarcinoma manifesting as ground glass opacity

“…This study collected the clinical data of 165 young patients who underwent VATS in our hospital between January 2017 and December 2018 and were pathologically diagnosed as lung adenocarcinoma, of which 133 patients’ lesions were GGO, and 32 patients’ lesions were SN. We found that both the GGO group and the SN group are mainly female and non-smokers, which is consistent with the findings of previous studies ( 15 , 18 ). It is worth noting that in our study, 23 patients had a family history of tumors, 11 of whom had a family history of lung cancer, while in Wu’s study ( 19 ), none of the 12 teenagers with lung adenocarcinoma had a family history of lung cancer.…”

The association between different hormone replacement therapy use and the incidence of lung cancer: a systematic review and meta-analysis

“…Cancer risk factors involved intrinsic and non-intrinsic factors (46), and the occurrence and development of lung cancer is a multi-factor and multi-step process (47). In addition to intrinsic risk factors for lung cancer, there are also many non-intrinsic risk factors including: tobacco smoking (48), environmental pollutants (48)(49), second- Author**, all the participants in these 4 cohort studies were postmenopausal women.…”

EML4‑ALK fusion gene in non‑small cell lung cancer (Review)

“…Lung cancer is the second most common cancer type worldwide and the malignant tumor with the highest mortality rate; it is also associated with poor survival following the initial diagnosis ( 1 ). Possibly due to the popularization of diagnostic imaging technology and the improvement in the awareness of physical examinations, more patients with lung cancer are being diagnosed at an early stage; however, a number of them are young ( 4 ).…”